1575-72-0
1575-72-0
Chemical Structure
(±)-2-Propyl-4-pentenoic acid
Synonym(s): 4-en-VPA; 2-Allylpentanoic acid
- CAS No.: 1575-72-0
- Formula:C8H14O2
- Molecular Weight:142.20
IUPAC Name: 2-propylpent-4-enoic acid
InChIKey: UMYDNZXEHYSVFY-UHFFFAOYSA-N
SMILES: C=CCC(CCC)C(O)=O
Biological Activity: (±)-2-Propyl-4-pentenoic acid (4-en-VPA) is a major toxic metabolite of Valproic acid. (±)-2-Propyl-4-pentenoic acid exhibits neuroteratogenicity[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(±)-2-Propyl-4-pentenoic acid | 98.0% | (±)-2-Propyl-4-pentenoic acid (4-en-VPA) is a major toxic metabolite of Valproic acid. (±)-2-Propyl-4-pentenoic acid exhibits neuroteratogenicity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-2-Propyl-4-pentenoic acid (Standard) | ≥98% | (±)-2-Propyl-4-pentenoic acid (Standard) is the analytical standard of (±)-2-Propyl-4-pentenoic acid. This product is intended for research and analytical applications. (±)-2-Propyl-4-pentenoic acid (4-en-VPA) is a major toxic metabolite of Valproic acid. (±)-2-Propyl-4-pentenoic acid exhibits neuroteratogenicity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.83
HY-W020188RDiallylacetic acid (Standard) -
Similarity Score 0.82
HY-W012922R2-Methyl-4-pentenoic Acid (Standard) -
Similarity Score 0.82
HY-10585Valproic acid -
Similarity Score 0.82
HY-W015665R2-Ethylhexanoic acid (Standard) -
Similarity Score 0.82
HY-W7877582-Propylpent-4-ynoic acid -
Similarity Score 0.81
HY-1283712-Methylhexanoic acid -
Similarity Score 0.80
HY-W015664R2-Methylheptanoic acid (Standard) -
Similarity Score 0.79
HY-W010516R2-Methylvaleric acid (Standard) -
Similarity Score 0.77
HY-W167682R2-(Propan-2-yl)pentanoic acid (Standard) -
Explore the MedChemAI to find more analogs
References
- [1]. W Tang, et, al. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics. Drug Metab Dispos. 1997 Feb;25(2):219-27. [Content Brief]
- [2]. Gofflot F, et, al. In vitro neuroteratogenicity of valproic acid and 4-en-VPA. Neurotoxicol Teratol. Jul-Aug 1995;17(4):425-35. [Content Brief]
